Alessandra Cesano

NanoString Technologies has named Alessandra Cesano as chief medical officer. Cesano most recently served as CMO at Cleave Bioscience. Prior to that, she was CMO and chief operations officer at Nodality. She has also held various management positions at Biogen Idec, Amgen, and SmithKline Beecham Pharmaceuticals. Cesano has also served as a visiting professor at the School of Oncology and School of Biotechnology at the University of Turin.


Jinghui Zhang

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.